Dr. Alan Tan explores circulating tumor DNA, its role in clinical trials and its potential impact on patients with renal cell ...

And essentially, in the JCO paper, we were showing that essentially ... whether it's the YESCARTA or BREYANZI study, the sample size, number of patients that were treated in the second-line ...

Partial response (PR): At least a 50% decrease in the nodes or nodal masses, without an increase in the size of other nodes, liver, or spleen. Stable disease (SD): When the patient has not achieved ...

The threat of antimicrobial resistance (AMR) is augmented in the immunocompromised host because of overutilization of broad-spectrum antimicrobial therapy and inappropriate use of diagnostic testing.

While both are called medullary carcinoma, these cancers differ in many ways: ...

Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.

In addition, all airlines impose size and weight restrictions on checked luggage (as well as size limitations on carry-on luggage). This guide will help you figure out what baggage fees to expect ...